Experimental nerve treatment aims to regrow damaged fibers
NCT ID NCT04153422
Summary
This study is testing whether intravenous immunoglobulin (IVIG) can help regrow damaged nerve fibers and reduce pain in people with autoimmune small fiber neuropathy. Researchers will enroll 20 adults who have specific antibodies linked to this painful nerve condition. Participants will receive either the IVIG treatment or a placebo for six months, with skin biopsies and pain assessments used to measure any improvement.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SMALL FIBER NEUROPATHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-••••
Locations
-
Endeavor Health
RECRUITINGGlenview, Illinois, 60026, United States
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.